Propeller Health Grabs 510(k) Clearance For Bronchodilator Sensor Upgrade
This article was originally published in The Gray Sheet
Executive Summary
FDA cleared Propeller Health’s newest iteration of its bronchodilator sensor indicated to help monitor and control asthma, COPD, and other respiratory disease.
You may also be interested in...
For Asthmapolis, The Name Changes And The Focus Too
Digital health startup Asthmapolis has changed its name to Propeller Health, reflecting its broader focus to include chronic obstructive pulmonary disease.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.